Learn More
In current practice, optimal placement of deep brain stimulators (DBSs) is an iterative procedure. A target is chosen pre-operatively based on anatomical landmarks identified on MR images. This point(More)
BACKGROUND The microTargeting™ platform (MTP) stereotaxy system (FHC Inc., Bowdoin, Me., USA) was FDA approved in 2001 utilizing rapid-prototyping technology to create custom platforms for human(More)